teclistamab,talquetamab,daratumumab
genmab,janssen
['redirectt-1', 'talquetamab', 'teclistamab']
watch the interview with dr. explaining the results of the clinical trial "redirectt-1", which explores the efficacy of teclistamab and talquetamab simultaneously in relapsed or refractory #myeloma patients. #eha2023 
A network of highly efficient, effective and sustainable myeloma and AL amyloidosis patient organisations across Europe